Lappe Mark — SEC insider filings

SEC reporting owner CIK 1366074. 16 insider filings on record with FilingPulse; latest filed 2026-10-14.

Transaction summary — filings shown

Covers all 16 filings on record, filed 2021-01-19 to 2026-10-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Inhibrx Biosciences, Inc. (INBX)Chief Executive Officer, Director827 legs · 209,040 sh · $6,908,472—4
Inhibrx, Inc. (INBX)Chief Executive Officer, Director8—17 legs · 104,060 sh · $2,821,1409

Insider filings — Lappe Mark

FiledFormIssuerReported transactionsSource
2026-10-144Inhibrx Biosciences, Inc. (INBX)Purchase (P): 2,470 @ $84.07 · Purchase (P): 2,470 @ $85.00 · Purchase (P): 100 @ $85.76 · Purchase (P): 2,449 @ $84.07 · Purchase (P): 2,451 @ $85.00 · Purchase (P): 100 @ $85.76EDGAR
2026-09-284Inhibrx Biosciences, Inc. (INBX)Purchase (P): 3,324 @ $98.87 · Purchase (P): 2,176 @ $99.60 · Purchase (P): 1,500 @ $98.88 · Purchase (P): 3,000 @ $101.70EDGAR
2026-09-084Inhibrx Biosciences, Inc. (INBX)Purchase (P): 5,895 @ $99.29 · Purchase (P): 6,605 @ $100.64 · Purchase (P): 1,100 @ $107.12 · Purchase (P): 500 @ $108.23 · Purchase (P): 1,219 @ $111.88 · Purchase (P): 9,681 @ $112.28EDGAR
2024-09-164Inhibrx Biosciences, Inc. (INBX)Purchase (P): 26,963 @ $15.05 · Purchase (P): 13,037 @ $17.13EDGAR
2024-09-104Inhibrx Biosciences, Inc. (INBX)Purchase (P): 26,000 @ $15.29 · Purchase (P): 9,500 @ $15.21 · Purchase (P): 8,500 @ $15.19EDGAR
2024-09-034Inhibrx Biosciences, Inc. (INBX)Purchase (P): 10,000 @ $14.03 · Purchase (P): 10,000 @ $14.02 · Purchase (P): 15,288 @ $15.66 · Purchase (P): 4,712 @ $16.31EDGAR
2024-08-224Inhibrx Biosciences, Inc. (INBX)Purchase (P): 27,055 @ $12.97 · Purchase (P): 12,945 @ $12.93EDGAR
2024-05-304Inhibrx, Inc. (INBX)Disposition to issuer (D): 2,486,192 @ $30 · Disposition to issuer (D): 500,000 @ $30 · Disposition to issuer (D): 59,462 @ $30 · Disposition to issuer (D): 100,000 (derivative) · Disposition to issuer (D): 145,000 (derivative)EDGAR
2024-05-304Inhibrx Biosciences, Inc. (INXB)Grant/award (A): 621,548 · Grant/award (A): 125,000 · Grant/award (A): 14,865 · Grant/award (A): 300,000 (derivative) @ $0EDGAR
2023-03-014Inhibrx, Inc. (INBX)
jointly with Lappe Family Trust
Sale (S): 60 @ $25.02EDGAR
2023-01-244Inhibrx, Inc. (INBX)
jointly with Lappe Family Trust
Sale (S): 21,665 @ $25.36 · Sale (S): 4,272 @ $25.71 · Sale (S): 63 @ $26.11EDGAR
2023-01-034Inhibrx, Inc. (INBX)Grant/award (A): 100,000 (derivative) @ $0EDGAR
2022-12-204Inhibrx, Inc. (INBX)
jointly with Lappe Family Trust
Sale (S): 25,246 @ $25.53 · Sale (S): 754 @ $26.29EDGAR
2022-11-184Inhibrx, Inc. (INBX)
jointly with Lappe Family Trust
Sale (S): 6,959 @ $25.36 · Sale (S): 4,106 @ $26.57 · Sale (S): 4,333 @ $27.45 · Sale (S): 1,767 @ $28.86 · Sale (S): 6,773 @ $30.15 · Sale (S): 912 @ $30.67 · +1 moreEDGAR
2022-10-184Inhibrx, Inc. (INBX)
jointly with Lappe Family Trust
Sale (S): 8,981 @ $28.66 · Sale (S): 14,006 @ $29.92 · Sale (S): 2,892 @ $30.81 · Sale (S): 121 @ $31.51EDGAR
2021-01-194Inhibrx, Inc. (INBX)
jointly with Lappe Family Trust
Gift (G): 500,000 @ $0 · Gift (G): 500,000 @ $0 · Grant/award (A): 145,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-01-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1366074 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs